Facebook
X
LinkedIn
ForwardMGB Glomerular Disease Conference 2026
This is a live activity.
The 1-Day Glomerular Disease Conference will bring together clinicians and researchers to discuss recent advances in the understanding and management of glomerular diseases. The program will highlight emerging therapeutic strategies, clinical trial updates, and practical considerations for incorporating new agents into patient care. Sessions will include expert lectures, interactive case discussions, and debates. The conference aims to provide attendees with up-to-date, actionable insights that bridge science and clinical practice.
Target Audience
This activity is intended for nephrologists taking care of patients with autoimmune and rare kidney disease.
Learning Objectives
Upon completion of this activity, participants will be able to:
- Identify and interpret recent evidence-based clinical trials in glomerular diseases and their impact on treatment strategies.
- Apply current data to the use of novel immunologic and complement-targeted therapies in clinical practice.
- Apply personalized approaches and nuanced decision-making to optimize patient outcomes in glomerular disease management.
Additional Information
| 8:30am | Welcome & Opening Remarks | Harish Seethapathy, MD |
| 8:45 | Session 1: Advances in Clinical Trials in Glomerular Disease | TBD |
| 9:30 | Session 2: Integrating New Therapies into Practice for IgA | TBD |
| 10:15 | Break |
| 10:30 | Session 3: Do Good Biomarkers Exist for Glomerular Disease? | TBD |
| 11:15 | Session 4: Do We Have Good Treatments for ANCA Vasculitis & Membranous Nephropathy? | TBD |
| 12:00pm | Lunch |
| 1:00 | Session 5: Lupus Nephritis Management: Is B-Cell Depletion Now the Cornerstone of Management in LN? | TBD |
| 2:00 | Session 6: Rare Glomerular Diseases & Emerging Therapies | TBD |
| 2:45 | Panel Discussion: Hot Takes in Glomerular Disease Treatment | TBD |
| 3:15 | Break |
| 3:30 | Patient Panel | Moderator TBD |
| 4:15 | Rapid-Fire Case Reviews & Clinical Pearls | TBD |
| 4:45 | Closing Remarks & Takeaways | TBD |
| 5:00pm | Adjournment |
Harish Seethapathy, MD - Course Director
Assistant Physician, Massachusetts General Hospital
Instructor, Harvard Medical School
In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statements
AMA PRA Category 1 CreditsTM
Mass General Brigham designates this live activity for a maximum of 6 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Available Credit
- 6.00 AMA PRA Category 1 Credit™
- 6.00 Participation